Scarica l'app Stockscreener
47.77
7.92%
3.505
Dopo l'orario di chiusura:
47.78
0.005
+0.01%
Lb Pharmaceuticals Inc Borsa (LBRX) Ultime notizie
LB Pharmaceuticals (NASDAQ:LBRX) Cut to Sell at Wall Street Zen - marketbeat.com
LB Pharmaceuticals (LBRX) investor group reports 5.0% beneficial stake in 13G/A - Stock Titan
Stifel raises LB Pharmaceuticals stock price target on pipeline outlook By Investing.com - Investing.com South Africa
Stifel raises LB Pharmaceuticals stock price target on pipeline outlook - Investing.com
LB PHARMACEUTICALS INC : LEERINK PARTNERS RAISES TARGET PRICE TO $55 FROM $40 - webull.com
LB Pharmaceuticals Inc Common Stock (NASDAQ: LBRX) Stock Price, News & Analysis - Kalkine
BMO Capital Markets Increases LB Pharmaceuticals (NASDAQ:LBRX) Price Target to $54.00 - MarketBeat
AVLN Stock Price and Chart — NASDAQ:AVLN - TradingView
LBRX SWOT Analysis: Key Insights from 10-Q Filing - GuruFocus
Form 8K LB Pharmaceuticals Inc For: 11 August - Investing.com India
LB Pharmaceuticals Inc Stock 12‑Month Price Target Raised to $47.67, Implies 4% Upside - TradingView
LB Pharmaceuticals Submits Q2 2026 SEC Form 10-Q Reporting 32.26M Shares Outstanding - Kalkine Media
LB Pharmaceuticals2026 Funding Rounds & List of Investors - Tracxn
LB Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet
Form 8K LB Pharmaceuticals Inc For: 11 August By Investing.com - Investing.com Nigeria
LB Pharmaceuticals Q2 Loss Per Share Narrows - Yahoo Finance
LB PHARMACEUTICALS INC Q2 2026: Revenue $0 Net loss $(51.6M), EPS $(1.71) — 10-Q Summary - TradingView
Earnings Flash (LBRX) LB Pharmaceuticals Posts Q2 Loss $1.71 a Share, vs. FactSet Est of $0.81 Loss - marketscreener.com
LB Pharmaceuticals reports Q2 2026 net loss of $51.6M, cash $327.8M; pivots LB-102 development - TradingView
LB Pharmaceuticals Q2 net loss widens on higher R&D costs - TradingView
LB Pharmaceuticals Inc.: Q2 Earnings Snapshot - The Daily Gazette
Press Release: LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update - moomoo.com
LB Pharmaceuticals (NASDAQ:LBRX) Sets New 52-Week HighTime to Buy? - MarketBeat
Janus Henderson Group PLC Takes Position in LB Pharmaceuticals Inc $LBRX - MarketBeat
LB Pharmaceuticals Inc (NASDAQ:LBRX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
HC Wainwright Issues Optimistic Estimate for LBRX Earnings - MarketBeat
Analysts Offer Insights on NA Companies: Evommune, Inc. (EVMN), LB Pharmaceuticals, Inc. (LBRX) and SpaceX (SPCX) - The Globe and Mail
Price to sales forward of LB Pharmaceuticals Inc – NASDAQ:LBRX - TradingView
Form 4 LB Pharmaceuticals Inc For: 3 August By Investing.com - Investing.com Canada
Piper Sandler reiterates Overweight on LB Pharmaceuticals stock - Investing.com
Piper Sandler reiterates Overweight on LB Pharmaceuticals stock By Investing.com - Investing.com Nigeria
LB Pharmaceuticals (NASDAQ:LBRX) Receives "Buy" Rating from HC Wainwright - MarketBeat
Enterprise value to revenue forward of LB Pharmaceuticals Inc – NASDAQ:LBRX - TradingView
LB Pharmaceuticals Inc Revenue Breakdown – NASDAQ:LBRX - TradingView
Stempoint Capital LP Takes $1.23 Million Position in LB Pharmaceuticals Inc $LBRX - MarketBeat
LB Pharmaceuticals raises $150M in private placement By Investing.com - Investing.com Nigeria
LB Pharmaceuticals Prices ~$150 Million Private Placement of Stock and Pre-Funded Warrants - TradingView
LB Pharmaceuticals Announces $150 Million Private Placement - GlobeNewswire
LB Pharmaceuticals Secures $150 Million via Private Placement to Advance LB-102 Pipeline Expansion - Kalkine Media
LB Pharmaceuticals (NASDAQ:LBRX) Hits New 1-Year HighWhat's Next? - MarketBeat
Eversept Partners LP Makes New $2.47 Million Investment in LB Pharmaceuticals Inc $LBRX - MarketBeat
LB Pharmaceuticals Inc (LBRX) Balance Sheet - TradingKey
LB Pharmaceuticals Inc (LBRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
LBRX|LB Pharmaceuticals Inc|Price:35.010|Chg%:+0.390 - TradingKey
LB Pharmaceuticals Inc (LBRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LB Pharmaceuticals Inc (LBRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LB Pharmaceuticals Inc (LBRX) Institutional Confidence - TradingKey
LB Pharmaceuticals Inc (LBRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
H.C. Wainwright Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $45 - Moomoo
LB Pharmaceuticals Inc $LBRX is Spruce Street Capital LP's 3rd Largest Position - MarketBeat
Enterprise value to revenue forward of LB Pharmaceuticals Inc – BOATS:LBRX - TradingView
H.C. Wainwright reiterates Buy on LB Pharmaceuticals stock By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Buy on LB Pharmaceuticals stock - Investing.com
LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target Maintained - TipRanks
LB Pharmaceuticals Inc (LBRX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Analysts Offer Insights on NA Companies: Exodus Movement, Inc. Class A (EXOD) and LB Pharmaceuticals, Inc. (LBRX) - The Globe and Mail
LB Pharmaceuticals Inc (LBRX) stock price, news, quote and history - Yahoo Finance Singapore
LB Pharmaceuticals (NASDAQ:LBRX) Reaches New 1-Year HighTime to Buy? - MarketBeat
LB Pharmaceuticals accelerates Phase 3 schizophrenia trial timeline - TipRanks
LB Pharmaceuticals accelerates schizophrenia trial timeline By Investing.com - Investing.com South Africa
LB Pharmaceuticals accelerates schizophrenia trial timeline - Investing.com
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):